The sickle cell disease drug developer, which is backed by Pfizer Ventures and Lundbeckfonden Ventures, has filed for an $86.3m IPO.

SoftBank is set to exit the mobile content discovery platform in an acquisition by Digital Turbine that is reportedly priced at $66m.

The payment app developer, which counts Sumitomo among its investors, is seeking $7.3m in a flotation on the Indonesia Stock Exchange.

The precision cancer therapy developer, based on research from several universities, floated at the top of an upsized range and saw its price continue to rise post-IPO.

The precision cancer therapy developer, which counts Sanofi as a significant shareholder, floated at the top of an upsized range and saw its price continue to rise post-IPO.

Goldman Sachs led a round that valued Flywire at more than $1bn as the digital payment processor acquired American Express-backed Simplee.

Legal & General increased its stake in the charging infrastructure operator to 23% while EDF purchased a majority share in a $130m deal.

Comcast Ventures has exited Hollar in an acquisition by Five Below, which is reportedly set to shut down the budget e-commerce platform.

Less than three years after raising money at a valuation of up to $1bn, Essential is shutting down after low sales of its alternative Android smartphone.

Biopsy verification technology developer Strand Diagnostics had raised $7.5m of a commitment from Nantworks originally slated to reach $30m.